← Back to Search

Nasal Congestion Relief Device

Sonu Treatment Group for Sinusitis (SCORE Trial)

N/A
Waitlist Available
Led By Jacob Johnson, MD
Research Sponsored by Third Wave Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks

Summary

This trial tests Sonu, a headband that uses sound vibrations from a smartphone app, to help people with severe nasal congestion due to rhinitis. The vibrations aim to clear the nasal passages and make breathing easier. The device has been studied for its effectiveness in reducing nasal congestion.

Eligible Conditions
  • Sinusitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary Effectiveness
Secondary study objectives
Secondary Effectiveness

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Sonu Treatment GroupExperimental Treatment1 Intervention
Patients will receive acoustic resonance therapy for 15 minutes, twice a day, for two weeks using Sonu.
Group II: Sham Control GroupPlacebo Group1 Intervention
Patients will receive non-resonant acoustic energy for 15 minutes, twice a day, for two weeks using Sonu.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sonu
2022
N/A
~60

Find a Location

Who is running the clinical trial?

Third Wave TherapeuticsLead Sponsor
3 Previous Clinical Trials
325 Total Patients Enrolled
Jacob Johnson, MDPrincipal InvestigatorSan Francisco Otolaryngology Medical Group
4 Previous Clinical Trials
341 Total Patients Enrolled
1 Trials studying Sinusitis
14 Patients Enrolled for Sinusitis

Media Library

Sonu (Nasal Congestion Relief Device) Clinical Trial Eligibility Overview. Trial Name: NCT05821842 — N/A
Sinusitis Research Study Groups: Sham Control Group, Sonu Treatment Group
Sinusitis Clinical Trial 2023: Sonu Highlights & Side Effects. Trial Name: NCT05821842 — N/A
Sonu (Nasal Congestion Relief Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05821842 — N/A
~15 spots leftby Nov 2025